BAA – Clinical Assays for Ebola, Anthrax and Melioidosis
The DHS Directorate of Science and Technology (S&T) is seeking performers for clinical assay development against high priority pathogens. The ...
The DHS Directorate of Science and Technology (S&T) is seeking performers for clinical assay development against high priority pathogens. The ...
Officials with the Centers for Disease Control and Prevention (CDC), along with the U. S. Department of Agriculture's (USDA) Animal ...
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information regarding efforts to develop therapeutic products that demonstrate activity ...
The U.S. Medical Research Institute of lnfectious Diseases (USAMRIID) has announced intentions to award a new contract to George Mason ...
Emergent BioSolutions today announced that it has acquired the lead broad-spectrum antibiotic candidate, currently receiving Defense Threat Reduction Agency (DTRA) development ...
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is seeking quotations for mass spectrometry analysis of proteins in support ...
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is seeking firms capable of providing research services to profile the ...
The 22nd International Conference on Biodetection Technologies 2014 will be held June 10-11, 2014 in Baltimore, Maryland. The conference is ...
The U.S. Army recently announced intentions to award a sole source contract to the University of Kansas (KU) Therapeutic Particles ...
Blood culture of burkholderia pseudomallei, the causative agent of melioidosis. Credit: CDC/Larry Stauffer The Defense Threat Reduction Agency (DTRA) has ...
The U.S. Department of Defense has recently awarded a notable contract related to the field of chemical, biological, radiological and ...
Burkholderia pseudomallei is a NIAID Category B Priority Pathogen for Biodefense. Image source: DTRA A new drug to help protect ...
Soligenix, Inc., announced this week it will jointly develop a treatment for Melioidosis, an infectious disease caused by a Gram-negative ...
The Biomedical Advanced Research and Development Authority (BARDA) has modified the Diagnostics portion of a funding effort for “Advanced Research ...
The U.S. Department of Defense has initiated a new research and development effort to address the continuing emergence of multi-drug ...
The U.S. military is seeking innovative ideas for development of technologies for chemical and biological defense applications under a Broad ...
The Defense Threat Reduction Agency (DTRA) Chemical and Biological Defense Program (CBDP) has extended the proposal receipt deadline for the ...
Apichai Tuanyok dedicated several years to working on a bacterial pathogen in Canada, but his breakthrough occurred in Flagstaff with an ...
The Defense Threat Reduction Agency (DTRA) Chemical and Biological Defense Program (CBDP) is soliciting innovative research proposals to develop nanostructured ...
The federal government this week unveiled plans for a new “tiered” designation of pathogens on the Select Agent and Toxins List. The ...